Free Trial

Marsh & McLennan Companies (MMC) Financials

Marsh & McLennan Companies logo
$210.38 -0.73 (-0.34%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$210.59 +0.21 (+0.10%)
As of 08/22/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Marsh & McLennan Companies

Annual Income Statements for Marsh & McLennan Companies

This table shows Marsh & McLennan Companies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
1,465 1,599 1,768 1,492 1,650 1,742 2,016 3,143 3,050 3,756 4,060
Consolidated Net Income / (Loss)
1,497 1,636 1,795 1,512 1,670 1,773 2,046 3,174 3,087 3,802 4,117
Net Income / (Loss) Continuing Operations
1,471 1,636 1,795 1,510 1,670 1,773 2,046 3,174 3,087 3,802 4,117
Total Pre-Tax Income
2,057 2,307 2,480 2,643 2,244 2,439 2,793 4,208 4,082 5,026 5,480
Total Revenue
12,707 12,781 13,027 13,796 14,659 16,157 16,951 19,439 20,287 22,241 23,853
Net Interest Income / (Expense)
-144 -150 -184 -228 -279 -485 -508 -442 -454 -500 -617
Total Interest Income
21 13 5.00 9.00 11 39 7.00 2.00 15 78 83
Investment Securities Interest Income
21 13 5.00 9.00 11 39 7.00 2.00 15 78 83
Total Interest Expense
165 163 189 237 290 524 515 444 469 578 700
Long-Term Debt Interest Expense
165 163 189 237 290 524 515 444 469 578 700
Total Non-Interest Income
12,851 12,931 13,211 14,024 14,938 16,642 17,459 19,881 20,741 22,741 24,470
Net Realized & Unrealized Capital Gains on Investments
-137 - - 0.00 -12 -10 235 61 21 5.00 12
Other Non-Interest Income
- - 13,211 14,024 14,950 16,652 17,224 19,820 20,720 22,736 24,458
Total Non-Interest Expense
10,650 10,474 10,547 11,369 12,189 13,975 14,158 15,508 16,440 17,454 18,641
Salaries and Employee Benefits
7,515 7,334 7,694 8,085 8,605 9,734 10,129 11,425 12,071 13,099 13,996
Other Operating Expenses
3,135 3,140 3,086 3,284 3,584 4,241 4,029 4,083 4,369 4,355 4,645
Nonoperating Income / (Expense), net
- - - 216 -226 257 - 277 235 239 268
Income Tax Expense
586 671 685 1,133 574 666 747 1,034 995 1,224 1,363
Net Income / (Loss) Attributable to Noncontrolling Interest
32 37 27 20 20 31 30 31 37 46 57
Basic Earnings per Share
$2.69 $3.01 $3.41 $2.91 $3.26 $3.44 $3.98 $6.20 $6.11 $7.60 $8.26
Weighted Average Basic Shares Outstanding
545M 531M 519M 513M 506M 506M 506M 507M 499M 494M 492M
Diluted Earnings per Share
$2.65 $2.98 $3.38 $2.87 $3.23 $3.41 $3.94 $6.13 $6.04 $7.53 $8.18
Weighted Average Diluted Shares Outstanding
553M 536M 524M 519M 511M 511M 512M 513M 505M 499M 496M
Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 506.10M 506.40M 0.00 0.00 0.00 0.00 0.00
Cash Dividends to Common per Share
$1.06 $1.18 $1.30 $1.43 $1.58 $1.74 $1.84 - $2.25 $2.60 $3.05

Quarterly Income Statements for Marsh & McLennan Companies

This table shows Marsh & McLennan Companies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
466 1,235 1,035 730 756 1,400 1,125 747 788 1,381 1,211
Consolidated Net Income / (Loss)
471 1,252 1,047 738 765 1,424 1,140 752 801 1,412 1,231
Net Income / (Loss) Continuing Operations
471 1,252 1,047 738 765 1,424 1,140 752 801 1,412 1,231
Total Pre-Tax Income
613 1,664 1,384 930 1,048 1,871 1,565 1,035 1,009 1,827 1,646
Total Revenue
10,447 5,804 5,743 5,254 5,440 6,352 6,078 5,556 5,867 6,840 6,743
Net Interest Income / (Expense)
-118 -122 -136 -129 -113 -122 -144 -142 -209 -226 -238
Total Interest Income
9.00 14 10 16 38 37 12 12 22 19 5.00
Investment Securities Interest Income
9.00 14 10 16 38 37 12 12 22 19 5.00
Total Interest Expense
127 136 146 145 151 159 156 154 231 245 243
Long-Term Debt Interest Expense
127 136 146 145 151 159 156 154 231 245 243
Total Non-Interest Income
10,565 5,926 5,879 5,383 5,553 6,474 6,222 5,698 6,076 7,066 6,981
Net Realized & Unrealized Capital Gains on Investments
-6.00 2.00 3.00 1.00 -1.00 1.00 1.00 1.00 9.00 5.00 7.00
Other Non-Interest Income
- 5,924 5,876 5,382 5,554 6,473 6,221 5,697 6,067 7,061 6,974
Total Non-Interest Expense
9,953 4,198 4,419 4,386 4,451 4,548 4,579 4,589 4,925 5,056 5,145
Salaries and Employee Benefits
3,038 3,207 3,337 3,287 3,268 3,470 3,454 3,442 3,630 3,850 3,895
Other Operating Expenses
1,304 991 1,082 1,099 1,183 1,078 1,125 1,147 1,295 1,206 1,250
Nonoperating Income / (Expense), net
- 58 60 62 59 67 66 68 67 43 48
Income Tax Expense
142 412 337 192 283 447 425 283 208 415 415
Net Income / (Loss) Attributable to Noncontrolling Interest
5.00 17 12 8.00 9.00 24 15 5.00 13 31 20
Basic Earnings per Share
$0.95 $2.50 $2.09 $1.48 $1.53 $2.84 $2.28 $1.52 $1.62 $2.81 $2.46
Weighted Average Basic Shares Outstanding
499M 495M 495M 494M 494M 492M 492M 492M 492M 492M 492M
Diluted Earnings per Share
$0.95 $2.47 $2.07 $1.47 $1.52 $2.82 $2.27 $1.51 $1.58 $2.79 $2.45
Weighted Average Diluted Shares Outstanding
505M 500M 499M 499M 499M 497M 496M 496M 496M 495M 495M
Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Dividends to Common per Share
- - - - - $1.42 $0.00 - - $1.63 $0.00

Annual Cash Flow Statements for Marsh & McLennan Companies

This table details how cash moves in and out of Marsh & McLennan Companies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-345 -584 -348 179 29 2,432 2,175 700 728 2,050 -478
Net Cash From Operating Activities
2,119 1,888 2,007 1,893 2,428 2,361 3,382 3,516 3,465 4,258 4,302
Net Cash From Continuing Operating Activities
2,119 1,888 2,007 1,893 2,428 2,361 3,382 3,516 3,465 4,258 4,302
Net Income / (Loss) Continuing Operations
1,497 1,636 1,795 1,512 1,670 1,773 2,046 3,174 3,087 3,802 4,117
Consolidated Net Income / (Loss)
1,497 1,636 1,795 1,512 1,670 1,773 2,046 3,174 3,087 3,802 4,117
Depreciation Expense
302 314 308 312 311 333 390 382 381 370 369
Amortization Expense
86 109 130 169 183 314 351 365 338 343 377
Non-Cash Adjustments to Reconcile Net Income
222 65 -36 -236 332 268 313 -380 -37 316 162
Changes in Operating Assets and Liabilities, net
12 -236 -190 136 -68 -327 282 -25 -304 -573 -723
Net Cash From Investing Activities
-1,222 -1,265 -1,056 -956 -1,089 -4,395 -793 -1,164 -850 -1,417 -8,821
Net Cash From Continuing Investing Activities
-1,222 -1,265 -1,056 -956 -1,089 -4,395 -793 -1,164 -850 -1,417 -8,821
Purchase of Property, Leasehold Improvements and Equipment
-368 -325 -253 -302 -314 -421 -348 -406 -470 -416 -316
Purchase of Investment Securities
-852 -1,017 -811 -668 - -4,203 -673 -28 -594 -1,022 -8,649
Divestitures
0.00 71 0.00 0.00 110 229 98 84 119 -17 89
Sale and/or Maturity of Investments
-5.00 4.00 4.00 6.00 4.00 - 130 45 95 38 55
Net Cash From Financing Activities
-968 -906 -1,067 -1,009 -1,310 4,331 -925 -1,297 -1,046 -1,119 4,455
Net Cash From Continuing Financing Activities
-968 -906 -1,067 -1,009 -1,310 4,331 -925 -1,297 -1,046 -1,119 4,455
Issuance of Debt
1,386 1,091 397 987 591 6,759 1,737 743 2,668 2,315 8,170
Issuance of Common Equity
263 224 188 166 93 158 132 161 126 199 264
Repayment of Debt
-1,096 -61 -12 -315 -263 -1,649 -2,515 -1,016 -365 -412 -1,617
Repurchase of Common Equity
-800 -1,400 -800 -900 -675 -485 0.00 -1,159 -1,950 -1,150 -900
Payment of Dividends
-582 -632 -682 -740 -807 -906 -977 -1,062 -1,165 -1,329 -1,553
Other Financing Activities, Net
-139 -128 -158 -207 -249 454 698 1,036 -360 -742 91
Effect of Exchange Rate Changes
-274 -301 -232 251 - 135 511 -355 -841 328 -414

Quarterly Cash Flow Statements for Marsh & McLennan Companies

This table details how cash moves in and out of Marsh & McLennan Companies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
692 -262 895 1,994 -577 -1,242 240 571 -47 -491 365
Net Cash From Operating Activities
1,502 -819 1,484 1,810 1,783 -781 1,215 1,912 1,956 -622 1,671
Net Cash From Continuing Operating Activities
1,502 -819 1,484 1,810 1,783 -781 1,215 1,912 1,956 -622 1,671
Net Income / (Loss) Continuing Operations
471 1,252 1,047 738 765 1,424 1,140 752 801 1,412 1,231
Consolidated Net Income / (Loss)
471 1,252 1,047 738 765 1,424 1,140 752 801 1,412 1,231
Depreciation Expense
122 84 91 95 100 99 87 90 93 88 91
Amortization Expense
80 85 87 85 86 90 89 90 108 139 140
Non-Cash Adjustments to Reconcile Net Income
-137 124 37 -163 318 -23 -8.00 -135 251 9.00 200
Changes in Operating Assets and Liabilities, net
966 -2,364 222 1,055 514 -2,371 -93 1,115 703 -2,270 9.00
Net Cash From Investing Activities
-487 -368 -133 -442 -474 -368 -415 -393 -7,645 26 -121
Net Cash From Continuing Investing Activities
-487 -368 -133 -442 -474 -368 -415 -393 -7,645 26 -121
Purchase of Property, Leasehold Improvements and Equipment
-103 -84 -101 -111 -120 -87 -80 -73 -76 -55 -59
Purchase of Investment Securities
-589 -1.00 -22 -640 -359 -311 -3.00 -1,047 -7,589 -28 -52
Divestitures
-19 -20 3.00 -1.00 1.00 26 1.00 79 -17 25 -10
Net Cash From Financing Activities
-1,074 773 -546 988 -2,334 135 -519 -1,436 6,275 -138 -1,695
Net Cash From Continuing Financing Activities
-1,074 773 -546 988 -2,334 135 -519 -1,436 6,275 -138 -1,695
Issuance of Debt
2,068 1,433 -336 2,442 -1,224 1,868 698 167 6,266 1,134 -984
Issuance of Common Equity
37 42 78 45 34 113 54 54 43 128 47
Repayment of Debt
-351 -4.00 -4.00 -150 -254 -1,004 -605 -4.00 -4.00 -505 -5.00
Repurchase of Common Equity
-350 -300 -300 -300 -250 -300 -300 -300 - -300 -300
Payment of Dividends
-305 -299 -302 -361 -367 -358 -369 -412 -414 -426 -418
Other Financing Activities, Net
-2,173 -99 318 -688 -273 -184 3.00 -941 384 -169 -35
Effect of Exchange Rate Changes
751 152 90 -362 448 -228 -41 488 -633 243 510

Annual Balance Sheets for Marsh & McLennan Companies

This table presents Marsh & McLennan Companies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
17,793 18,216 18,190 20,429 21,578 31,357 33,049 34,388 44,114 48,030 56,481
Cash and Due from Banks
1,958 1,374 1,026 1,205 1,066 1,155 2,089 1,752 12,102 3,358 2,398
Restricted Cash
- - - - - - - - - 10,794 11,276
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -160 -151 0.00
Accrued Investment Income
3,142 3,198 3,370 3,777 3,984 4,608 4,679 5,093 5,293 5,806 6,533
Premises and Equipment, Net
809 773 725 712 701 858 856 847 871 882 859
Unearned Premiums Asset
50 51 83 65 79 123 112 136 103 103 84
Goodwill
- - - 9,089 9,599 14,671 15,517 16,317 16,251 17,231 23,306
Intangible Assets
692 8,925 9,495 1,274 1,437 2,774 2,699 2,810 2,537 2,630 4,820
Other Assets
11,142 3,895 3,491 4,307 4,712 7,168 7,097 7,433 7,117 7,377 7,205
Total Liabilities & Shareholders' Equity
17,793 18,216 18,190 20,429 21,578 31,357 33,049 34,388 44,114 48,030 56,481
Total Liabilities
10,660 11,614 11,918 12,987 13,994 23,414 23,789 23,166 33,365 35,660 42,946
Short-Term Debt
11 12 312 262 755 1,215 517 17 268 1,619 519
Accrued Interest Payable
150 154 146 199 157 179 247 198 221 321 376
Other Short-Term Payables
3,516 3,542 3,624 3,801 4,012 5,285 5,792 6,439 17,343 17,855 18,623
Long-Term Debt
3,368 4,402 4,495 5,225 5,510 10,741 10,796 10,933 11,227 11,844 19,428
Other Long-Term Liabilities
3,615 3,504 3,341 3,500 3,560 5,994 6,437 5,579 4,306 4,021 4,000
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
7,133 6,602 6,272 7,442 7,584 7,943 9,260 11,222 10,749 12,370 13,535
Total Preferred & Common Equity
7,054 6,513 6,192 7,359 7,511 7,793 9,104 11,009 10,520 12,191 13,342
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
7,054 6,513 6,192 7,359 7,511 7,793 9,104 11,009 10,520 12,191 13,342
Common Stock
1,491 1,422 1,403 1,345 1,378 1,423 1,504 1,673 1,740 1,803 1,931
Retained Earnings
10,335 11,302 12,388 13,140 14,347 15,199 16,272 18,389 20,301 22,759 25,306
Treasury Stock
-925 -1,991 -2,506 -3,083 -3,567 -3,774 -3,562 -4,478 -6,207 -7,076 -7,655
Accumulated Other Comprehensive Income / (Loss)
-3,847 -4,220 -5,093 -4,043 -4,647 -5,055 -5,110 -4,575 -5,314 -5,295 -6,240
Noncontrolling Interest
79 89 80 83 73 150 156 213 229 179 193

Quarterly Balance Sheets for Marsh & McLennan Companies

This table presents Marsh & McLennan Companies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets
44,114 34,358 46,566 48,000 48,030 47,572 48,591 49,864 56,481 57,015 58,555
Cash and Due from Banks
12,102 1,006 12,735 14,729 3,358 12,910 1,653 1,798 2,398 1,604 1,677
Restricted Cash
- - - - 10,794 - 11,497 11,923 11,276 11,579 11,871
Loans and Leases, Net of Allowance
-160 0.00 0.00 0.00 -151 0.00 0.00 0.00 -167 0.00 0.00
Accrued Investment Income
5,293 5,966 6,406 5,909 5,806 6,509 7,031 6,783 6,533 7,215 7,751
Premises and Equipment, Net
871 867 870 859 882 877 879 884 859 840 839
Unearned Premiums Asset
103 98 97 102 103 107 119 102 84 101 105
Goodwill
16,251 16,300 16,621 16,655 17,231 17,314 17,516 18,235 23,306 23,538 23,919
Intangible Assets
2,537 2,452 2,508 2,498 2,630 2,631 2,638 2,720 4,820 4,736 4,770
Other Assets
7,117 7,669 7,329 7,248 7,377 7,224 7,258 7,419 7,372 7,402 7,623
Total Liabilities & Shareholders' Equity
44,114 34,358 46,566 48,000 48,030 47,572 48,591 49,864 56,481 57,015 58,555
Total Liabilities
33,365 23,162 34,427 36,414 35,660 34,950 35,026 35,982 42,946 42,747 42,579
Short-Term Debt
268 2,403 2,375 2,219 1,619 1,518 1,267 919 519 2,067 769
Accrued Interest Payable
221 356 407 480 321 456 505 565 376 554 619
Other Short-Term Payables
17,343 5,155 17,031 17,906 17,855 16,686 17,092 18,120 18,623 17,154 18,012
Long-Term Debt
11,227 10,841 10,247 11,781 11,844 12,300 12,278 12,330 19,428 18,862 18,960
Other Long-Term Liabilities
4,306 4,407 4,367 4,028 4,021 3,990 3,884 4,048 4,000 4,110 4,219
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
10,749 11,196 12,139 11,586 12,370 12,622 13,565 13,882 13,535 14,268 15,976
Total Preferred & Common Equity
10,520 10,953 11,961 11,406 12,191 12,422 13,367 13,688 13,342 14,065 15,767
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
10,520 10,953 11,961 11,406 12,191 12,422 13,367 13,688 13,342 14,065 15,767
Common Stock
1,740 1,625 1,635 1,711 1,803 1,673 1,758 1,850 1,931 1,814 1,923
Retained Earnings
20,301 20,949 21,980 22,007 22,759 23,456 24,578 24,520 25,306 25,881 27,088
Treasury Stock
-6,207 -6,387 -6,599 -6,852 -7,076 -7,198 -7,442 -7,692 -7,655 -7,734 -8,000
Accumulated Other Comprehensive Income / (Loss)
-5,314 -5,234 -5,055 -5,460 -5,295 -5,509 -5,527 -4,990 -6,240 -5,896 -5,244
Noncontrolling Interest
229 243 178 180 179 200 198 194 193 203 209

Annual Metrics And Ratios for Marsh & McLennan Companies

This table displays calculated financial ratios and metrics derived from Marsh & McLennan Companies' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.52% 0.58% 1.92% 5.90% 6.26% 10.22% 4.91% 14.68% 4.36% 9.63% 7.25%
EBITDA Growth
4.89% 11.66% 6.89% -0.34% 1.93% -4.55% 24.92% 32.37% -2.39% 20.46% 8.33%
EBIT Growth
4.26% 12.15% 7.50% -2.14% 1.77% -11.66% 28.00% 40.74% -2.14% 24.43% 8.88%
NOPAT Growth
6.67% 11.22% 9.72% -22.75% 32.57% -13.71% 28.99% 44.92% -1.88% 24.47% 8.13%
Net Income Growth
8.09% 9.29% 9.72% -15.77% 10.45% 6.17% 15.40% 55.13% -2.74% 23.16% 8.29%
EPS Growth
9.05% 12.45% 13.42% -15.09% 12.54% 5.57% 15.54% 55.58% -1.47% 24.67% 8.63%
Operating Cash Flow Growth
58.02% -10.90% 6.30% -5.68% 28.26% -2.76% 43.24% 3.96% -1.45% 22.89% 1.03%
Free Cash Flow Firm Growth
7,096.30% -40.07% 53.00% -126.76% 298.14% -586.15% 130.74% -0.43% 107.70% -98.87% -11,692.60%
Invested Capital Growth
-3.82% 4.79% 0.57% 16.70% 7.12% 43.69% 3.39% 7.77% 0.32% 16.13% 29.61%
Revenue Q/Q Growth
0.11% 1.73% 0.18% 2.28% 0.06% 3.02% 2.81% 2.50% 36.28% -18.38% 1.82%
EBITDA Q/Q Growth
-2.51% 7.69% 1.14% -4.72% 4.07% -2.18% 9.85% 3.36% -7.63% 9.54% -0.53%
EBIT Q/Q Growth
-3.29% 8.62% 1.47% -6.22% 5.02% -4.67% 11.59% 4.46% -9.44% 11.53% -0.89%
NOPAT Q/Q Growth
-2.52% 7.28% 3.52% -27.89% 19.44% -3.82% 10.31% 7.98% -15.01% 3.23% 0.69%
Net Income Q/Q Growth
-0.53% 5.28% 3.46% -21.37% 8.37% 15.43% -0.82% 15.59% -9.82% 8.38% 0.88%
EPS Q/Q Growth
-0.38% 6.43% 3.68% -21.37% 8.39% 15.59% -1.25% 16.10% -9.31% 8.19% 0.74%
Operating Cash Flow Q/Q Growth
11.12% -4.02% -0.20% -6.84% 17.01% -1.63% 10.20% 1.71% 1.76% 7.07% 4.19%
Free Cash Flow Firm Q/Q Growth
1,757.02% -56.83% 67.18% -158.00% 103.14% 11.59% 91.95% -61.82% -1.31% 105.15% -259.29%
Invested Capital Q/Q Growth
-13.03% 0.24% -5.21% 0.91% -0.36% -3.39% -5.35% 6.06% 3.69% 0.97% 23.41%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
19.24% 21.36% 22.40% 21.08% 20.22% 17.51% 20.85% 24.07% 22.51% 24.73% 24.98%
EBIT Margin
16.19% 18.05% 19.04% 17.59% 16.85% 13.51% 16.48% 20.22% 18.96% 21.52% 21.85%
Profit (Net Income) Margin
11.78% 12.80% 13.78% 10.96% 11.39% 10.97% 12.07% 16.33% 15.22% 17.09% 17.26%
Tax Burden Percent
72.78% 70.91% 72.38% 57.21% 74.42% 72.69% 73.25% 75.43% 75.62% 75.65% 75.13%
Interest Burden Percent
100.00% 100.00% 100.00% 108.90% 90.85% 111.78% 100.00% 107.05% 106.11% 104.99% 105.14%
Effective Tax Rate
28.49% 29.09% 27.62% 42.87% 25.58% 27.31% 26.75% 24.57% 24.38% 24.35% 24.87%
Return on Invested Capital (ROIC)
13.72% 15.20% 16.25% 11.55% 13.73% 9.40% 10.11% 13.87% 13.10% 15.06% 13.20%
ROIC Less NNEP Spread (ROIC-NNEP)
14.54% 15.20% 16.25% 13.99% 10.87% 11.45% 10.11% 15.75% 14.68% 16.51% 14.41%
Return on Net Nonoperating Assets (RNNOA)
6.10% 8.62% 11.64% 10.50% 8.50% 13.44% 13.68% 17.12% 15.00% 17.83% 18.58%
Return on Equity (ROE)
19.82% 23.82% 27.89% 22.05% 22.23% 22.84% 23.79% 30.99% 28.10% 32.89% 31.79%
Cash Return on Invested Capital (CROIC)
17.62% 10.52% 15.68% -3.86% 6.86% -26.45% 6.78% 6.39% 12.78% 0.13% -12.59%
Operating Return on Assets (OROA)
11.83% 12.81% 13.62% 12.57% 11.76% 8.24% 8.67% 11.66% 9.80% 10.39% 9.97%
Return on Assets (ROA)
8.61% 9.09% 9.86% 7.83% 7.95% 6.70% 6.35% 9.41% 7.86% 8.25% 7.88%
Return on Common Equity (ROCE)
19.62% 23.53% 27.52% 21.79% 22.00% 22.51% 23.36% 30.43% 27.54% 32.31% 31.33%
Return on Equity Simple (ROE_SIMPLE)
21.22% 25.12% 28.99% 20.55% 22.23% 22.75% 22.47% 28.83% 29.34% 31.19% 30.86%
Net Operating Profit after Tax (NOPAT)
1,471 1,636 1,795 1,387 1,838 1,586 2,046 2,965 2,909 3,621 3,916
NOPAT Margin
11.58% 12.80% 13.78% 10.05% 12.54% 9.82% 12.07% 15.25% 14.34% 16.28% 16.42%
Net Nonoperating Expense Percent (NNEP)
-0.82% 0.00% 0.00% -2.44% 2.86% -2.05% 0.00% -1.88% -1.58% -1.45% -1.21%
SG&A Expenses to Revenue
59.14% 57.38% 59.06% 58.60% 58.70% 60.25% 59.75% 58.77% 59.50% 58.90% 58.68%
Operating Expenses to Revenue
83.81% 81.95% 80.96% 82.41% 83.15% 86.50% 83.52% 79.78% 81.04% 78.48% 78.15%
Earnings before Interest and Taxes (EBIT)
2,057 2,307 2,480 2,427 2,470 2,182 2,793 3,931 3,847 4,787 5,212
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,445 2,730 2,918 2,908 2,964 2,829 3,534 4,678 4,566 5,500 5,958
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.70 3.82 4.95 5.06 4.89 6.72 6.17 7.67 7.55 7.52 7.79
Price to Tangible Book Value (P/TBV)
4.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.05 1.95 2.35 2.70 2.50 3.24 3.32 4.34 3.92 4.12 4.36
Price to Earnings (P/E)
17.81 15.57 17.34 24.96 22.24 30.04 27.88 26.85 26.05 24.42 25.60
Dividend Yield
2.20% 2.47% 2.19% 1.96% 2.17% 1.68% 1.66% 1.20% 1.40% 1.40% 1.78%
Earnings Yield
5.61% 6.42% 5.77% 4.01% 4.50% 3.33% 3.59% 3.72% 3.84% 4.09% 3.91%
Enterprise Value to Invested Capital (EV/IC)
2.63 2.54 3.12 3.22 3.03 3.18 3.19 4.23 3.55 3.53 3.30
Enterprise Value to Revenue (EV/Rev)
2.17 2.19 2.65 3.02 2.86 3.92 3.87 4.83 3.90 4.10 4.63
Enterprise Value to EBITDA (EV/EBITDA)
11.29 10.27 11.83 14.31 14.16 22.37 18.56 20.05 17.32 16.59 18.53
Enterprise Value to EBIT (EV/EBIT)
13.42 12.15 13.92 17.14 16.99 29.00 23.48 23.86 20.55 19.06 21.18
Enterprise Value to NOPAT (EV/NOPAT)
18.76 17.14 19.23 30.00 22.83 39.90 32.05 31.63 27.18 25.19 28.19
Enterprise Value to Operating Cash Flow (EV/OCF)
13.02 14.85 17.20 21.98 17.29 26.81 19.39 26.68 22.82 21.42 25.66
Enterprise Value to Free Cash Flow (EV/FCFF)
14.61 24.76 19.93 0.00 45.71 0.00 47.80 68.66 27.87 2,832.66 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.67 0.77 0.74 0.83 1.51 1.22 0.98 1.07 1.09 1.47
Long-Term Debt to Equity
0.47 0.67 0.72 0.70 0.73 1.35 1.17 0.97 1.04 0.96 1.44
Financial Leverage
0.42 0.57 0.72 0.75 0.78 1.17 1.35 1.09 1.02 1.08 1.29
Leverage Ratio
2.30 2.62 2.83 2.82 2.80 3.41 3.74 3.29 3.57 3.99 4.03
Compound Leverage Factor
2.30 2.62 2.83 3.07 2.54 3.81 3.74 3.52 3.79 4.18 4.24
Debt to Total Capital
32.14% 40.07% 43.39% 42.44% 45.24% 60.08% 54.99% 49.39% 51.68% 52.12% 59.58%
Short-Term Debt to Total Capital
0.10% 0.11% 2.82% 2.03% 5.45% 6.11% 2.51% 0.08% 1.20% 6.27% 1.55%
Long-Term Debt to Total Capital
32.04% 39.96% 40.57% 40.41% 39.79% 53.98% 52.48% 49.31% 50.47% 45.85% 58.03%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.75% 0.81% 0.72% 0.64% 0.53% 0.75% 0.76% 0.96% 1.03% 0.69% 0.58%
Common Equity to Total Capital
67.10% 59.12% 55.89% 56.92% 54.24% 39.16% 44.25% 49.65% 47.29% 47.19% 39.85%
Debt to EBITDA
1.38 1.62 1.65 1.89 2.11 4.23 3.20 2.34 2.52 2.45 3.35
Net Debt to EBITDA
0.58 1.11 1.30 1.47 1.75 3.82 2.61 1.97 -0.13 -0.13 1.05
Long-Term Debt to EBITDA
1.38 1.61 1.54 1.80 1.86 3.80 3.05 2.34 2.46 2.15 3.26
Debt to NOPAT
2.30 2.70 2.68 3.96 3.41 7.54 5.53 3.69 3.95 3.72 5.09
Net Debt to NOPAT
0.97 1.86 2.11 3.09 2.83 6.81 4.51 3.10 -0.21 -0.19 1.60
Long-Term Debt to NOPAT
2.29 2.69 2.50 3.77 3.00 6.77 5.28 3.69 3.86 3.27 4.96
Noncontrolling Interest Sharing Ratio
0.99% 1.22% 1.31% 1.19% 1.04% 1.44% 1.78% 1.80% 2.01% 1.76% 1.44%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,889 1,132 1,732 -463 918 -4,464 1,372 1,366 2,837 32 -3,733
Operating Cash Flow to CapEx
580.55% 584.52% 806.02% 643.88% 780.71% 560.81% 971.84% 866.01% 737.23% 1,023.56% 1,361.39%
Free Cash Flow to Firm to Interest Expense
11.45 6.94 9.16 -1.96 3.17 -8.52 2.66 3.08 6.05 0.06 -5.33
Operating Cash Flow to Interest Expense
12.84 11.58 10.62 7.99 8.37 4.51 6.57 7.92 7.39 7.37 6.15
Operating Cash Flow Less CapEx to Interest Expense
10.63 9.60 9.30 6.75 7.30 3.70 5.89 7.00 6.39 6.65 5.69
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.73 0.71 0.72 0.71 0.70 0.61 0.53 0.58 0.52 0.48 0.46
Fixed Asset Turnover
15.52 16.16 17.39 19.20 20.75 20.73 19.78 22.83 23.62 25.37 27.40
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,512 11,016 11,079 12,929 13,849 19,899 20,573 22,172 22,244 25,833 33,482
Invested Capital Turnover
1.19 1.19 1.18 1.15 1.09 0.96 0.84 0.91 0.91 0.93 0.80
Increase / (Decrease) in Invested Capital
-418 504 63 1,850 920 6,050 674 1,599 72 3,589 7,649
Enterprise Value (EV)
27,598 28,033 34,514 41,602 41,972 63,287 65,584 93,798 79,073 91,225 110,397
Market Capitalization
26,098 24,904 30,653 37,237 36,700 52,336 56,204 84,387 79,451 91,735 103,931
Book Value per Share
$13.04 $12.49 $12.01 $14.42 $14.91 $15.44 $17.95 $21.80 $21.21 $24.72 $27.17
Tangible Book Value per Share
$11.76 ($4.62) ($6.41) ($5.89) ($7.00) ($19.13) ($17.97) ($16.08) ($16.67) ($15.56) ($30.10)
Total Capital
10,512 11,016 11,079 12,929 13,849 19,899 20,573 22,172 22,244 25,833 33,482
Total Debt
3,379 4,414 4,807 5,487 6,265 11,956 11,313 10,950 11,495 13,463 19,947
Total Long-Term Debt
3,368 4,402 4,495 5,225 5,510 10,741 10,796 10,933 11,227 11,844 19,428
Net Debt
1,421 3,040 3,781 4,282 5,199 10,801 9,224 9,198 -607 -689 6,273
Capital Expenditures (CapEx)
365 323 249 294 311 421 348 406 470 416 316
Net Nonoperating Expense (NNE)
-26 0.00 0.00 -125 168 -187 0.00 -209 -178 -181 -201
Net Nonoperating Obligations (NNO)
3,379 4,414 4,807 5,487 6,265 11,956 11,313 10,950 11,495 13,463 19,947
Total Depreciation and Amortization (D&A)
388 423 438 481 494 647 741 747 719 713 746
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.69 $3.01 $3.41 $2.91 $3.26 $3.44 $3.98 $6.20 $6.11 $7.60 $8.26
Adjusted Weighted Average Basic Shares Outstanding
545M 531M 519M 513M 506M 506M 506M 507M 499M 494M 492M
Adjusted Diluted Earnings per Share
$2.65 $2.98 $3.38 $2.87 $3.23 $3.41 $3.94 $6.13 $6.04 $7.53 $8.18
Adjusted Weighted Average Diluted Shares Outstanding
553M 536M 524M 519M 511M 511M 512M 513M 505M 499M 496M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $3.44 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 503.90M 508.19M 502.77M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
1,471 1,636 1,626 1,387 1,838 1,586 2,046 2,965 2,909 3,621 3,916
Normalized NOPAT Margin
11.58% 12.80% 12.48% 10.05% 12.54% 9.82% 12.07% 15.25% 14.34% 16.28% 16.42%
Pre Tax Income Margin
16.19% 18.05% 19.04% 19.16% 15.31% 15.10% 16.48% 21.65% 20.12% 22.60% 22.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
12.47 14.15 13.12 10.24 8.52 4.16 5.42 8.85 8.20 8.28 7.45
NOPAT to Interest Expense
8.92 10.04 9.50 5.85 6.34 3.03 3.97 6.68 6.20 6.27 5.59
EBIT Less CapEx to Interest Expense
10.25 12.17 11.80 9.00 7.44 3.36 4.75 7.94 7.20 7.56 6.99
NOPAT Less CapEx to Interest Expense
6.70 8.06 8.18 4.61 5.27 2.22 3.30 5.76 5.20 5.55 5.14
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
38.88% 38.63% 37.99% 48.94% 48.32% 51.10% 47.75% 33.46% 37.74% 34.96% 37.72%
Augmented Payout Ratio
92.32% 124.21% 82.56% 108.47% 88.74% 78.45% 47.75% 69.97% 100.91% 65.20% 59.58%

Quarterly Metrics And Ratios for Marsh & McLennan Companies

This table displays calculated financial ratios and metrics derived from Marsh & McLennan Companies' official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
107.04% 7,092.77% 9.02% 12.87% -47.93% 9.44% 5.83% 5.75% 7.85% 7.68% 10.94%
EBITDA Growth
-35.14% 10.66% 5.70% 24.02% 68.82% 12.28% 11.52% 9.45% -2.72% 0.90% 9.19%
EBIT Growth
-44.80% 12.78% 5.67% 28.40% 100.20% 12.33% 13.22% 11.41% -4.75% -1.11% 6.60%
NOPAT Growth
-37.33% 11.27% 7.24% 35.30% 53.28% 13.63% 9.02% 2.00% 3.58% 0.42% 9.45%
Net Income Growth
-41.64% 15.29% 7.06% 33.70% 62.42% 13.74% 8.88% 1.90% 4.71% -0.84% 7.98%
EPS Growth
-39.49% 17.62% 8.38% 36.11% 60.00% 14.17% 9.66% 2.72% 3.95% -1.06% 7.93%
Operating Cash Flow Growth
4.16% -16.67% 15.76% 30.87% 18.71% 4.64% -18.13% 5.64% 9.70% 20.36% 37.53%
Free Cash Flow Firm Growth
147.08% 94.01% -40.38% -8,748.31% -818.56% -951.31% -20.36% 75.54% -140.71% -1,076.76% -488.66%
Invested Capital Growth
0.32% 5.47% 9.01% 19.27% 16.13% 8.18% 9.49% 6.04% 29.61% 33.12% 31.70%
Revenue Q/Q Growth
124.43% -44.44% -1.05% -8.51% 3.54% 16.76% -4.31% -8.59% 5.60% 16.58% -1.42%
EBITDA Q/Q Growth
-17.63% 155.03% -15.38% -30.23% 12.12% 69.62% -15.96% -31.52% -0.35% 75.94% -9.05%
EBIT Q/Q Growth
-26.92% 225.10% -17.56% -34.44% 13.94% 82.41% -16.91% -35.49% -2.59% 89.38% -10.43%
NOPAT Q/Q Growth
-7.48% 156.55% -17.11% -31.23% 4.81% 90.19% -20.47% -35.66% 6.44% 84.37% -13.32%
Net Income Q/Q Growth
-14.67% 165.82% -16.37% -29.51% 3.66% 86.14% -19.94% -34.04% 6.52% 76.28% -12.82%
EPS Q/Q Growth
-12.04% 160.00% -16.19% -28.99% 3.40% 85.53% -19.50% -33.48% 4.64% 76.58% -12.19%
Operating Cash Flow Q/Q Growth
8.60% -154.53% 281.20% 21.97% -1.49% -143.80% 255.57% 57.37% 2.30% -131.80% 368.65%
Free Cash Flow Firm Q/Q Growth
1,125.05% -114.95% -1,651.17% -229.78% 16.76% 78.13% -100.49% 32.99% -719.22% -6.91% -0.29%
Invested Capital Q/Q Growth
3.69% 9.87% 1.31% 3.33% 0.97% 2.35% 2.53% 0.08% 23.41% 5.12% 1.44%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
6.66% 30.58% 26.15% 19.95% 21.60% 31.38% 27.56% 20.64% 19.48% 29.40% 27.12%
EBIT Margin
4.73% 27.67% 23.05% 16.52% 18.18% 28.40% 24.66% 17.40% 16.06% 26.08% 23.70%
Profit (Net Income) Margin
4.51% 21.57% 18.23% 14.05% 14.06% 22.42% 18.76% 13.53% 13.65% 20.64% 18.26%
Tax Burden Percent
76.84% 75.24% 75.65% 79.35% 73.00% 76.11% 72.84% 72.66% 79.39% 77.29% 74.79%
Interest Burden Percent
124.09% 103.61% 104.53% 107.14% 105.97% 103.71% 104.40% 107.03% 107.11% 102.41% 103.00%
Effective Tax Rate
23.16% 24.76% 24.35% 20.65% 27.00% 23.89% 27.16% 27.34% 20.61% 22.71% 25.21%
Return on Invested Capital (ROIC)
4.12% 22.89% 19.58% 15.19% 12.28% 19.36% 16.02% 11.24% 10.25% 15.92% 14.11%
ROIC Less NNEP Spread (ROIC-NNEP)
4.12% 23.24% 19.95% 15.57% 12.62% 19.74% 16.39% 11.60% 10.57% 16.11% 14.33%
Return on Net Nonoperating Assets (RNNOA)
4.21% 26.26% 21.13% 18.69% 13.63% 22.43% 16.68% 12.41% 13.63% 20.82% 16.14%
Return on Equity (ROE)
8.33% 49.15% 40.71% 33.88% 25.91% 41.79% 32.70% 23.65% 23.88% 36.74% 30.25%
Cash Return on Invested Capital (CROIC)
12.78% 8.34% 5.38% -2.66% 0.13% 7.02% 5.89% 8.89% -12.59% -15.69% -14.55%
Operating Return on Assets (OROA)
2.44% 21.29% 15.36% 11.25% 8.78% 15.80% 11.99% 8.33% 7.33% 12.14% 11.06%
Return on Assets (ROA)
2.33% 16.59% 12.15% 9.57% 6.79% 12.47% 9.12% 6.48% 6.23% 9.61% 8.52%
Return on Common Equity (ROCE)
8.16% 48.13% 40.00% 33.24% 25.45% 41.01% 32.22% 23.30% 23.54% 36.19% 29.83%
Return on Equity Simple (ROE_SIMPLE)
0.00% 29.70% 27.77% 30.76% 0.00% 31.99% 30.43% 29.81% 0.00% 29.19% 26.61%
Net Operating Profit after Tax (NOPAT)
471 1,208 1,002 689 722 1,373 1,092 703 748 1,379 1,195
NOPAT Margin
4.51% 20.82% 17.44% 13.11% 13.27% 21.62% 17.97% 12.65% 12.75% 20.16% 17.72%
Net Nonoperating Expense Percent (NNEP)
0.00% -0.35% -0.37% -0.38% -0.35% -0.38% -0.37% -0.36% -0.32% -0.19% -0.22%
SG&A Expenses to Revenue
29.08% 55.26% 58.11% 62.56% 60.07% 54.63% 56.83% 61.95% 61.87% 56.29% 57.76%
Operating Expenses to Revenue
95.27% 72.33% 76.95% 83.48% 81.82% 71.60% 75.34% 82.60% 83.94% 73.92% 76.30%
Earnings before Interest and Taxes (EBIT)
494 1,606 1,324 868 989 1,804 1,499 967 942 1,784 1,598
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
696 1,775 1,502 1,048 1,175 1,993 1,675 1,147 1,143 2,011 1,829
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.55 7.36 7.64 8.09 7.52 8.12 7.74 7.99 7.79 8.49 6.83
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.92 3.08 3.43 3.39 4.12 4.42 4.47 4.67 4.36 4.91 4.31
Price to Earnings (P/E)
26.05 25.08 27.84 26.63 24.42 25.72 25.79 27.14 25.60 29.56 26.10
Dividend Yield
1.40% 1.41% 1.28% 1.33% 1.40% 1.33% 1.35% 1.64% 1.78% 1.59% 1.49%
Earnings Yield
3.84% 3.99% 3.59% 3.76% 4.09% 3.89% 3.88% 3.69% 3.91% 3.38% 3.83%
Enterprise Value to Invested Capital (EV/IC)
3.55 3.81 3.69 3.59 3.53 3.86 3.84 4.02 3.30 3.62 3.20
Enterprise Value to Revenue (EV/Rev)
3.90 3.56 3.43 3.37 4.10 4.47 4.50 4.65 4.63 5.23 4.56
Enterprise Value to EBITDA (EV/EBITDA)
17.32 19.65 18.98 18.27 16.59 17.83 17.66 18.20 18.53 21.32 18.62
Enterprise Value to EBIT (EV/EBIT)
20.55 23.10 22.30 21.38 19.06 20.45 20.16 20.73 21.18 24.54 21.57
Enterprise Value to NOPAT (EV/NOPAT)
27.18 28.61 27.52 26.16 25.19 26.93 26.84 28.04 28.19 32.49 28.36
Enterprise Value to Operating Cash Flow (EV/OCF)
22.82 27.80 25.76 23.07 21.42 23.73 25.83 26.40 25.66 28.56 23.21
Enterprise Value to Free Cash Flow (EV/FCFF)
27.87 46.89 71.65 0.00 2,832.66 57.09 68.12 46.52 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.07 1.18 1.04 1.21 1.09 1.09 1.00 0.95 1.47 1.47 1.23
Long-Term Debt to Equity
1.04 0.97 0.84 1.02 0.96 0.97 0.91 0.89 1.44 1.32 1.19
Financial Leverage
1.02 1.13 1.06 1.20 1.08 1.14 1.02 1.07 1.29 1.29 1.13
Leverage Ratio
3.57 3.04 3.47 3.74 3.99 3.44 3.70 3.84 4.03 3.89 3.63
Compound Leverage Factor
4.43 3.15 3.63 4.01 4.22 3.57 3.87 4.11 4.32 3.98 3.74
Debt to Total Capital
51.68% 54.19% 50.98% 54.72% 52.12% 52.26% 49.96% 48.83% 59.58% 59.46% 55.26%
Short-Term Debt to Total Capital
1.20% 9.83% 9.59% 8.67% 6.27% 5.74% 4.67% 3.39% 1.55% 5.87% 2.15%
Long-Term Debt to Total Capital
50.47% 44.36% 41.38% 46.04% 45.85% 46.52% 45.29% 45.45% 58.03% 53.59% 53.10%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.03% 0.99% 0.72% 0.70% 0.69% 0.76% 0.73% 0.72% 0.58% 0.58% 0.59%
Common Equity to Total Capital
47.29% 44.82% 48.31% 44.58% 47.19% 46.98% 49.31% 50.45% 39.85% 39.96% 44.16%
Debt to EBITDA
2.52 2.80 2.62 2.79 2.45 2.42 2.30 2.21 3.35 3.50 3.22
Net Debt to EBITDA
-0.13 2.58 -0.02 -0.15 -0.13 0.16 0.07 -0.08 1.05 1.30 1.01
Long-Term Debt to EBITDA
2.46 2.29 2.13 2.35 2.15 2.15 2.08 2.06 3.26 3.16 3.09
Debt to NOPAT
3.95 4.07 3.80 3.99 3.72 3.65 3.49 3.41 5.09 5.34 4.90
Net Debt to NOPAT
-0.21 3.76 -0.03 -0.21 -0.19 0.24 0.10 -0.12 1.60 1.98 1.54
Long-Term Debt to NOPAT
3.86 3.33 3.08 3.36 3.27 3.25 3.17 3.17 4.96 4.81 4.71
Noncontrolling Interest Sharing Ratio
2.01% 2.07% 1.74% 1.90% 1.76% 1.86% 1.46% 1.47% 1.44% 1.50% 1.38%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
399 -60 -1,044 -3,444 -2,867 -627 -1,257 -842 -6,901 -7,378 -7,400
Operating Cash Flow to CapEx
1,458.25% -975.00% 1,469.31% 1,630.63% 1,485.83% -897.70% 1,518.75% 2,619.18% 2,573.68% -1,130.91% 2,832.20%
Free Cash Flow to Firm to Interest Expense
3.14 -0.44 -7.15 -23.75 -18.99 -3.94 -8.06 -5.47 -29.88 -30.12 -30.45
Operating Cash Flow to Interest Expense
11.83 -6.02 10.16 12.48 11.81 -4.91 7.79 12.42 8.47 -2.54 6.88
Operating Cash Flow Less CapEx to Interest Expense
11.02 -6.64 9.47 11.72 11.01 -5.46 7.28 11.94 8.14 -2.76 6.63
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.77 0.67 0.68 0.48 0.56 0.49 0.48 0.46 0.47 0.47
Fixed Asset Turnover
23.62 30.22 30.75 31.61 25.37 26.13 26.44 26.88 27.40 28.35 29.11
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
22,244 24,440 24,761 25,586 25,833 26,440 27,110 27,131 33,482 35,197 35,705
Invested Capital Turnover
0.91 1.10 1.12 1.16 0.93 0.90 0.89 0.89 0.80 0.79 0.80
Increase / (Decrease) in Invested Capital
72 1,268 2,046 4,133 3,589 2,000 2,349 1,545 7,649 8,757 8,595
Enterprise Value (EV)
79,073 93,081 91,431 91,752 91,225 101,937 104,031 109,025 110,397 127,399 114,120
Market Capitalization
79,451 80,600 91,366 92,301 91,735 100,829 103,438 109,303 103,931 119,450 107,730
Book Value per Share
$21.21 $22.15 $24.18 $23.09 $24.72 $25.25 $27.13 $27.83 $27.17 $28.64 $32.00
Tangible Book Value per Share
($16.67) ($15.77) ($14.49) ($15.68) ($15.56) ($15.29) ($13.77) ($14.78) ($30.10) ($28.93) ($26.23)
Total Capital
22,244 24,440 24,761 25,586 25,833 26,440 27,110 27,131 33,482 35,197 35,705
Total Debt
11,495 13,244 12,622 14,000 13,463 13,818 13,545 13,249 19,947 20,929 19,729
Total Long-Term Debt
11,227 10,841 10,247 11,781 11,844 12,300 12,278 12,330 19,428 18,862 18,960
Net Debt
-607 12,238 -113 -729 -689 908 395 -472 6,273 7,746 6,181
Capital Expenditures (CapEx)
103 84 101 111 120 87 80 73 76 55 59
Net Nonoperating Expense (NNE)
0.00 -44 -45 -49 -43 -51 -48 -49 -53 -33 -36
Net Nonoperating Obligations (NNO)
11,495 13,244 12,622 14,000 13,463 13,818 13,545 13,249 19,947 20,929 19,729
Total Depreciation and Amortization (D&A)
202 169 178 180 186 189 176 180 201 227 231
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.95 $2.50 $2.09 $1.48 $1.53 $2.84 $2.28 $1.52 $1.62 $2.81 $2.46
Adjusted Weighted Average Basic Shares Outstanding
499M 495M 495M 494M 494M 492M 492M 492M 492M 492M 492M
Adjusted Diluted Earnings per Share
$0.95 $2.47 $2.07 $1.47 $1.52 $2.82 $2.27 $1.51 $1.58 $2.79 $2.45
Adjusted Weighted Average Diluted Shares Outstanding
505M 500M 499M 499M 499M 497M 496M 496M 496M 495M 495M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
471 1,208 1,002 689 722 1,373 1,092 703 748 1,379 1,195
Normalized NOPAT Margin
4.51% 20.82% 17.44% 13.11% 13.27% 21.62% 17.97% 12.65% 12.75% 20.16% 17.72%
Pre Tax Income Margin
5.87% 28.67% 24.10% 17.70% 19.26% 29.46% 25.75% 18.63% 17.20% 26.71% 24.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.89 11.81 9.07 5.99 6.55 11.35 9.61 6.28 4.08 7.28 6.58
NOPAT to Interest Expense
3.71 8.89 6.86 4.75 4.78 8.64 7.00 4.56 3.24 5.63 4.92
EBIT Less CapEx to Interest Expense
3.08 11.19 8.38 5.22 5.76 10.80 9.10 5.81 3.75 7.06 6.33
NOPAT Less CapEx to Interest Expense
2.90 8.27 6.17 3.98 3.99 8.09 6.49 4.09 2.91 5.40 4.68
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
37.74% 36.43% 36.24% 36.12% 34.96% 34.93% 35.78% 36.90% 37.72% 39.49% 39.80%
Augmented Payout Ratio
100.91% 90.22% 79.89% 71.75% 65.20% 63.87% 64.05% 65.08% 59.58% 61.41% 61.25%

Key Financial Trends

Marsh & McLennan Companies (NYSE: MMC) has shown steady financial performance over the past several years, highlighted by consistent profitability, manageable debt levels, and strong cash flows. Here are the key trends and insights based on the financial data from 2022 through mid-2025:

  • Consistent Net Income Growth: Consolidated net income has increased from $471 million in Q4 2022 to $1.23 billion in Q2 2025, demonstrating strong profitability growth over the period.
  • Increasing Earnings Per Share (EPS): Basic EPS rose significantly from $0.95 in Q4 2022 to $2.46 in Q2 2025, indicating improved earnings generation per share.
  • Strong Operational Cash Flow: Net cash from continuing operating activities exceeded $1.6 billion in Q2 2025, reflecting robust cash generation from core business operations.
  • Controlled Capital Expenditures: Investment in property and equipment averaged around $55-$128 million quarterly, showing disciplined capital spending relative to operating cash flow.
  • Maintained Dividend Payments: The company consistently paid dividends each quarter, with per share dividends growing from $1.42 in Q1 2024 to near $0 in recent quarters, reflecting a commitment to returning value to shareholders.
  • Share Repurchase Programs: Large-scale common equity repurchases (~$300 million per quarter) have been ongoing, enhancing shareholder value and reducing share count.
  • Total Assets Growth: Total assets increased from about $32 billion at Q3 2022 to nearly $59 billion by Q2 2025, indicating expansion but also possible asset accumulation to monitor.
  • Stable Debt Profile: Long-term debt remained relatively stable around $10-19 billion, while short-term debt fluctuated but stayed below $3 billion, showing consistent leverage management.
  • Goodwill and Intangible Assets Increase: Goodwill rose to about $23.9 billion by Q2 2025 from $15.5 billion in Q3 2022, suggesting acquisitions; intangible assets also increased.
  • Net Interest Expense: The company experienced rising net interest expense from $113 million in Q4 2023 up to approximately $243 million in Q2 2025, which could pressure net income if rates rise further.
  • Declining Net Cash from Operating Activities Q1 2025: Notably, Q1 2025 showed negative net cash from continuing operating activities (-$622 million), which reversed sharply in Q2 2025; this volatility warrants monitoring.
  • Increasing Accumulated Other Comprehensive Loss: The negative accumulated other comprehensive income expanded to about -$5.2 billion by Q2 2025, potentially reflecting unfavorable pension or foreign currency impacts affecting equity.

Overall, Marsh & McLennan demonstrates strong earnings growth, solid cash flow generation, and a consistent return to shareholders via dividends and share buybacks. The company’s asset growth and acquisitions appear to fuel expansion, though the rising interest expenses and occasional operating cash flow volatility should be watched closely. Investors can view MMC as a stable, growing insurance and consulting firm with a tested history of generating shareholder value, balanced with some exposure to macroeconomic factors like interest rates and currency movements.

08/23/25 06:52 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Marsh & McLennan Companies' Financials

When does Marsh & McLennan Companies' financial year end?

According to the most recent income statement we have on file, Marsh & McLennan Companies' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Marsh & McLennan Companies' net income changed over the last 10 years?

Marsh & McLennan Companies' net income appears to be on an upward trend, with a most recent value of $4.12 billion in 2024, rising from $1.50 billion in 2014. The previous period was $3.80 billion in 2023. Check out Marsh & McLennan Companies' forecast to explore projected trends and price targets.

How has Marsh & McLennan Companies' revenue changed over the last 10 years?

Over the last 10 years, Marsh & McLennan Companies' total revenue changed from $12.71 billion in 2014 to $23.85 billion in 2024, a change of 87.7%.

How much debt does Marsh & McLennan Companies have?

Marsh & McLennan Companies' total liabilities were at $42.95 billion at the end of 2024, a 20.4% increase from 2023, and a 302.9% increase since 2014.

How much cash does Marsh & McLennan Companies have?

In the past 10 years, Marsh & McLennan Companies' cash and equivalents has ranged from $1.03 billion in 2016 to $12.10 billion in 2022, and is currently $2.40 billion as of their latest financial filing in 2024.

How has Marsh & McLennan Companies' book value per share changed over the last 10 years?

Over the last 10 years, Marsh & McLennan Companies' book value per share changed from 13.04 in 2014 to 27.17 in 2024, a change of 108.3%.



This page (NYSE:MMC) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners